Niranjan Kameswaran | SVP, Strategy |
Mark Iwicki | Chairman, President & CEO |
Todd Bazemore | COO |
Mary Reumuth | CFO & Treasurer |
Andreas Argyrides | Wedbush Securities |
Christopher Neyor | JPMorgan Chase & Co. |
François Brisebois | Oppenheimer |
Tazeen Ahmad | Bank of America Merrill Lynch |
Yi Chen | H.C. Wainwright & Co. |
Timothy Chiang | Northland Capital Markets |
Kelly Shi | Jefferies |
Good morning and welcome to Kala Pharmaceuticals' First Quarter 2021 Financial Results Conference Call. [Operator Instructions].
As a reminder, this call is being recorded. I would now like to turn the call over to Niranjan Kameswaran, Senior Vice President of Strategy for Kala Pharmaceuticals. Please proceed.